Clinical Trials Directory

Trials / Completed

CompletedNCT01912118

The Medasense Study

Measurement of Nociceptive Index During General Anesthesia in ASA 1-3 Patients Undergoing Elective Surgery Using the Nociception Level (NoL) Index

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
96 (actual)
Sponsor
Leiden University Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Despite various efforts there is still the need for adequate monitoring of pain and nociception during anesthesia. In a previous protocol the investigators measured pain responses during anesthesia based on single end-points, eg heart rate,blood pressure and pulse transit time. None of these parameters provided sufficient information regarding nociception. The investigators therefore want to further investigate this matter using a composite parameter, the Nociception Level or NoL. The NoL is a novel index that measures the magnitude of the autonomic response to painful stimuli. The NoL combines information from several physiological parameters, which represent different autonomic pathways. The multi-parameter approach empowered with state-of-the-art signal processing and machine learning techniques. In the current study the investigators will measure the NoL in ASA 1-3 patients undergoing elective surgery under general anesthesia. The investigators will measure NoL responses and the occurrence of patient movement upon the administration of a painful stimulus: Introduction of the laryngoscope, Insertion of the endotracheal tube, Insertion of the gastric tube, Insertion of the bladder catheter and Skin incision.

Conditions

Interventions

TypeNameDescription
DRUGPropofolPropofol will be titrated via a target controlled infusion to reach a specific target BIS (as specified in treatment arm)
DRUGRemifentanilRemifentanil will be provided by a target controlled infusion to a specific effect site concentration (as specified in treatment arm)

Timeline

Start date
2013-07-01
Primary completion
2014-06-01
Completion
2014-09-01
First posted
2013-07-30
Last updated
2015-04-06

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01912118. Inclusion in this directory is not an endorsement.